Erik H J G Aarntzen Selected Research

Radiotherapy

1/2019

PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik H J G Aarntzen Research Topics

Disease

33	Neoplasms (Cancer) 12/2022 - 12/2007
20	Melanoma (Melanoma, Malignant) 03/2020 - 01/2009
3	Infections 01/2022 - 01/2017
3	Hypersensitivity (Allergy) 11/2019 - 09/2011
2	Neoplasm Metastasis (Metastasis) 12/2022 - 05/2012
2	Communicable Diseases (Infectious Diseases) 01/2022 - 11/2011
2	Bacteremia 07/2019 - 01/2017
1	Extranodal Extension 12/2022
1	Adenocarcinoma 10/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022
1	Disease Progression 10/2022
1	Squamous Cell Carcinoma of Head and Neck 10/2022
1	Staphylococcal Infections 10/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 09/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Periodontitis 01/2021
1	Arteritis 01/2021
1	Essential Hypertension 01/2021
1	Heart Failure 03/2020
1	Inflammation (Inflammations) 01/2020
1	Atherosclerosis 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2019
1	Foreign Bodies (Foreign Body) 07/2019
1	Fever (Fevers) 07/2019
1	Endocarditis 07/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Lymphatic Metastasis 01/2016
1	Uveal melanoma 11/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2012
1	Vitiligo 01/2009

Drug/Important Bio-Agent (IBA)

14	AntigensIBA 10/2022 - 12/2007
12	Monophenol Monooxygenase (Tyrosinase)IBA 03/2020 - 01/2009
9	Peptides (Polypeptides)IBA 07/2016 - 01/2009
7	VaccinesIBA 03/2020 - 01/2009
6	Messenger RNA (mRNA)IBA 03/2020 - 04/2009
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022 - 01/2017
5	CytokinesIBA 07/2016 - 12/2007
5	Neoplasm Antigens (Tumor Antigens)IBA 03/2016 - 04/2009
4	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 03/2016 - 09/2011
2	B7-H1 AntigenIBA 10/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	MART-1 AntigenIBA 08/2014 - 05/2012
2	HLA-A Antigens (HLA-A)IBA 03/2013 - 01/2013
1	durvalumabIBA 10/2022
1	ProgranulinsIBA 10/2022
1	LipopolysaccharidesIBA 01/2022
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022
1	Radioisotopes (Radionuclides)IBA 09/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AldosteroneIBA 01/2020
1	Protamines (Protamine Sulfate)FDA Link 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	pembrolizumabIBA 01/2019
1	Everolimus FDA Link 10/2018
1	exemestane (Aromasin)FDA Link 10/2018
1	Dinoprostone (PGE2)FDA Link 03/2016
1	ChemokinesIBA 01/2016
1	Melanoma-Specific AntigensIBA 11/2014
1	Interleukin-4 (Interleukin 4)IBA 08/2014
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2013
1	Carrier Proteins (Binding Protein)IBA 11/2012
1	Vaccine AdjuvantsIBA 11/2012
1	HaptensIBA 11/2012
1	Immunoglobulin G (IgG)IBA 11/2012
1	Immunoglobulin M (IgM)IBA 11/2012
1	SurvivinIBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	InterleukinsIBA 09/2011
1	RNA (Ribonucleic Acid)IBA 07/2009
1	Proteins (Proteins, Gene)FDA Link 07/2009
1	Indium-111IBA 04/2009
1	ferric oxide (iron oxide)IBA 04/2009
1	Differentiation AntigensIBA 01/2009
1	Interleukin-2 (IL2)IBA 01/2009

Therapy/Procedure

13	Immunotherapy 11/2019 - 07/2008
9	Therapeutics 01/2021 - 07/2009
4	Lymph Node Excision (Lymph Node Dissection) 07/2016 - 09/2011
2	Intravenous Injections 10/2021 - 03/2016
1	Cytoreduction Surgical Procedures 12/2022
1	Treatment Delay 11/2019
1	Castration 11/2019
1	Duration of Therapy 07/2019
1	Radiotherapy 01/2019
1	Injections 02/2013